7th International Workshop on Osteoarthritis Imaging report: "Imaging in OA - now is the time to move ahead"

Osteoarthritis and Cartilage

Volumn 23, Issue 6, 2015, Pages 888-896

  Guermazi, A ^a   Eckstein, F ^b   Hunter, D ^c,d   Roemer, F ^a,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anti NGF therapy; Imaging workshop; Osteoarthritis

Indexed keywords

NERVE GROWTH FACTOR ANTIBODY; ANALGESIC AGENT; NERVE GROWTH FACTOR;

ARTICLE; BONE RADIOGRAPHY; HUMAN; ICELAND; JOINT PROSTHESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RISK FACTOR; WORKSHOP; ANTAGONISTS AND INHIBITORS; COMPLICATION; DIAGNOSTIC IMAGING; MOLECULARLY TARGETED THERAPY; PAIN; PROCEDURES; TRENDS;

ANALGESICS, NON-NARCOTIC; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR TARGETED THERAPY; NERVE GROWTH FACTOR; OSTEOARTHRITIS; PAIN; RISK FACTORS;

EID: 84929708105     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.02.004     Document Type: Article

References (65)

1. Lynch JA, Liu F, Jungmann P, Lane N, Link T, Nevitt MC. Quantitative Joint Space Width Loss Measured in Hips with Radiographic Osteoarthritis from the Osteoarthritis Initiative. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:11.
2. Kwoh CK, Hannon MJ, Fujii T, Guermazi A, Boudreau R, Hunter DJ, etal. Recent Knee Injury of Knee Surgery is Associated with Worsening Findings on MRI within 12 Months Prior the Development of Incident Radiographic Osteoarthritis: Data from the Osteoarthritis Initiative. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:12.
3. Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ, Boudreau R, Eckstein F, etal. MRI-Based Long Term Prediction of Incident Radiographic Osteoarthritis: Data from the Osteoarthritis Initiative. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:14.
4. Thompson L.R., Boudreau R., Hannon M.J., Newman A.B., Chu C.R., Jansen M., et al. The knee pain map: reliability of a method to identify knee pain location and pattern. Arthritis Rheum 2009, 61:725-731.
5. Cotofana S, Hannon MJ, Eckstein F, Grago J, Wirth W, Hunter DJ, etal. Are Denuded Areas of Subchondral Bone Related to Localized Knee or Regional Pain as Evaluated by the Knee Pain Map? - Data from the Osteoarthritis Initiative. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:15.
6. Schiphof D., Oei E.H., Hofman A., Waarsing J.H., Weinans H., Bierma-Zeinstra S.M. Sensitivity and associations with pain and body weight of an MRI definition of knee osteoarthritis compared with radiographic Kellgren and Lawrence criteria: a population-based study in middle-aged females. Osteoarthr Cartil 2014, 22:440-446.
7. Hunter D.J., Guermazi A., Lo G.H., Grainger A.J., Conaghan P.G., Boudreau R.M., et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthr Cartil 2011, 19:990-1002.
8. Roos E.M., Lohmander L.S. Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes 2003, 1:64.
9. Hunter D.J., Arden N., Conaghan P.G., Eckstein F., Gold G., Grainger A., et al. Definition of osteoarthritis on MRI: results of a Delphi exercise. Osteoarthr Cartil 2011, 19:963-969.
10. Schiphof D, Oei EHG, Waarsing JH, Bierma-Zeinstra SMA. KOOS Scores Differ with Uni- or Bilateral Knee OA Based on MRI. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:16.
11. Runhaar J, van Middelkoop M, Reijman M, Oei EHG, Bierma-Zeinstra SMA. Comparing Radiographs and MRI for the Prediction of Incident Knee OA and Knee Pain in Overweight and Obese Women after 30 Months. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:25.
12. Ratzlaff C, Russel R, Duryea J. Quantitatively-Measured Bone Marrow Lesions in the Patellofemoral Joint: Distribution and Association with Pain. The 7th OARSI International Workshop on Osteoarthritis Imaging Abstract Book 2014:13.
13. Carrino JA. MRI Advances and Application in OA Assessment (2D vs. 3D, High Field Strength MRI, Ultrashort Echo (UTE) MRI). The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, Abstract Book:5.
14. Peterfy C.G., Schneider E., Nevitt M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthr Cartil 2008, 16:1433-1441.
15. Roemer F.W., Guermazi A., Lynch J.A., Peterfy C.G., Nevitt M.C., Webb N., et al. Short tau inversion recovery and proton density-weighted fat suppressed sequences for the evaluation of osteoarthritis of the knee with a 1.0 T dedicated extremity MRI: development of a time-efficient sequence protocol. Eur Radiol 2005, 15(5):978-987.
16. Gold G.E., Chen C.A., Koo S., Hargreaves B.A., Bangerter N.K. Recent advances in MRI of articular cartilage. AJR Am J Roentgenol 2009, 193:628-638.
17. Crema M.D., Roemer F.W., Marra M.D., Burstein D., Gold G.E., Eckstein F., et al. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. Radiographics 2011, 31:37-61.
18. Roemer F.W., Crema M.D., Trattnig S., Guermazi A. State of the art: advances in imaging of osteoarthritis and cartilage. Radiology 2011, 260:332-354.
19. Hayashi D., Guermazi A., Kwoh C.K., Hannon M.J., Moore C., Jakicic J.M., et al. Semiquantitative assessment of subchondral bone marrow edema-like lesions and subchondral cysts of the knee at 3T MRI: a comparison between intermediate-weighted fat-suppressed spin echo and dual echo steady state sequences. BMC Musculoskelet Disord 2011 Sep 9, 12:198.
20. Roemer F.W., Kwoh C.K., Hannon M.J., Crema M.D., Moore C., Jakicic J., et al. Semiquantitative assessment of focal cartilage damage at 3T MRI: a comparative study of dual echo at steady state (DESS) and intermediate-weighted (IW) fat suppressed fast spin echo sequences. Eur J Radiol 2011, 80(2):e126-e131.
21. Hayashi D., Roemer F.W., Guermazi A. Choice of pulse sequences for magnetic resonance imaging-based semiquantitative assessment of cartilage defects in osteoarthritis research: comment on the article by Dore etal. Arthritis Rheum 2010, 62:3830-3831.
22. Kijowski R., Davis K.W., Woods M.A., Lindstrom M.J., De Smet A.A., Gold G.E., et al. Knee joint: comprehensive assessment with 3D isotropic resolution fast spin-echo MR imaging-diagnostic performance compared with that of conventional MR imaging at 3.0 T. Radiology 2009, 252:486-495.
23. Kijowski R., Blankenbaker D.G., Davis K.W., Shinki K., Kaplan L.D., De Smet A.A. Comparison of 1.5- and 3.0-T MR imaging for evaluating the articular cartilage of the knee joint. Radiology 2009, 250:839-848.
24. Jung J.Y., Yoon Y.C., Kwon J.W., Ahn J.H., Choe B.K. Diagnosis of internal derangement of the knee at 3.0-T MR imaging: 3D isotropic intermediate-weighted versus 2D sequences. Radiology 2009, 253:780-787.
25. Saupe N., Prussmann K.P., Luechinger R., Bosiger P., Marincek B., Weishaupt D. MR imaging of the wrist: comparison between 1.5- and 3-T MR imaging-preliminary experience. Radiology 2005, 234:256-264.
26. Kuhl C.K., Traber F., Gieseke J., Drahanowsky W., Morakkabati-Spitz N., Willinek W., et al. Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part II. Technical considerations and clinical applications. Radiology 2008, 247:16-35.
27. Chang K.J., Kamel I.R., Macura K.J., Bluemke D.A. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics 2008, 28:1983-1998.
28. Du J., Takahashi A.M., Chung C.B. Ultrashort TE spectroscopic imaging (UTESI): application to the imaging of short T2 relaxation tissues in the musculoskeletal system. JMagn Reson Imaging 2009, 29:412-421.
29. Gold G.E., Pauly J.M., Macovski A. Herfkens RJMR spectroscopic imaging of collagen: tendons and knee menisci. Magn Reson Med 1995, 34:647-654.
30. Chu C.R., Williams A.A., West R.V., Qian Y., Fu F.H., Do B.H., et al. Quantitative magnetic resonance imaging UTE-T2* mapping of cartilage and meniscus healing after anatomic anterior cruciate ligament reconstruction. Am J Sports Med 2014, 42:1847-1856.
31. Bae W.C., Du J., Bydder G.M., Chung C.B. Conventional and ultrashort time-to-echo magnetic resonance imaging of articular cartilage, meniscus, and intervertebral disk. Top Magn Reson Imaging 2010, 21:275-289.
32. Tyler D.J., Robson M.D., Henkelman R.M., Young I.R., Bydder G.M. Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. JMagn Reson Imaging 2007, 25:279-289.
33. Kashyap S, Sonka M. Automated Algorithm for 3D MR Segmentation and Sub-plate Detection in 3D MRI-data from the Osteoarthritis Initiative. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, abstract book:21.
34. Segal NA, Frick E, Duryea J, Nevitt MC, Niu J, Torner JC, etal. Comparison of Measurements of Tibiofemoral Joint Space width from Standing CT and Fixed Flexion Radiography. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, Abstract Book:20.
35. Wang A, Abramson E, Pedoia V, Kretzschmar M, Nardo L, Link TM, etal. MR T1ρ and T2 of Meniscus after Acute Anterior Cruciate Ligament Injuries. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, abstract book:19.
36. Crema MD, Hunter DJ, Burstein D, Roemer FW, Li L, Krishnan N, etal. Changes in Delayed Gadolinium-Ehnaced MR of Tibiofemoral Cartilage (dGEMRIC) Indices are not Associated with Cartilaeg Loss Over 1 Year: a Longitudinal 3.0T MRI Study. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, abstract book:22.
37. Engelke K, Chappard C, Lowitz T, Museyko O, Laouisset L, Bousson V, etal. Quantitative Analysis of Subchondral Bone Structure in Knee OA at Different Levels of Spatial Resolution using Clinical Whole Body and High Resolution Peripheral CT Scanners. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, abstract book:17.
38. Pedoia V, Lansdown D, Zaid M, Ma CB, Li X. 3D MRI Based Analysis of the Knee Shape In Patients with ACL Injuries. The 7th OARSI International Workshop on Osteoarthritis Imaging 2014, Abstract Book:18.
39. Zhang Y., Niu J., Felson D.T., Choi H.K., Nevitt M., Neogi T. Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res Hob 2010, 62(11):1527-1532.
40. Sattler M., Dannhauer T., Hudelmaier M., Wirth W., Sänger A.M., Kwoh C.K., et al. Side differences of thigh muscle cross-sectional areas and maximal isometric muscle force in bilateral knees with the same radiographic disease stage, but unilateral frequent pain - data from the osteoarthritis initiative. Osteoarthr Cartil 2012, 20(6):532-540.
41. Ruhdorfer A., Wirth W., Hitzl W., Nevitt M., Eckstein F. Association of thigh muscle strength with knee symptoms and radiographic disease stage of osteoarthritis: data from the osteoarthritis initiative. Arthritis Care Res Hob 2014, 66(9):1344-1353.
42. Maschek S., Wirth W., Ladel C., Hellio Le Graverand M.P., Eckstein F. Rates and sensitivity of knee cartilage thickness loss in specific central reading radiographic strata from the osteoarthritis initiative. Osteoarthr Cartil 2014, 22(10):1550-1553.
43. Losina E., Paltiel A.D., Weinstein A.M., Yelin E., Hunter D.J., Chen S.P., et al. Lifetime medical costs of knee osteoarthritis management in the United States: Impact of extending indications for total knee arthroplasty. Arthritis Care Res Hob 2014 Jul 21, [Epub ahead of print]. 10.1002/acr.22412.
44. Roemer F.W., Kwoh C.K., Hannon M.J., Hunter D.J., Eckstein F., Wang Z., et al. Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year?. Radiology 2014 Oct 3, 140991. [Epub ahead of print].
45. Eckstein F., Boudreau R.M., Wang Z., Hannon M.J., Wirth W., Cotofana S., et al. Trajectory of cartilage loss within 4 years of knee replacement - a nested case-control study from the osteoarthritis initiative. Osteoarthr Cartil 2014, 22(10):1542-1549.
46. Englund M., Guermazi A., Roemer F.W., Yang M., Zhang Y., Nevitt M.C., et al. Meniscal pathology on MRI increases the risk for both incident and enlarging subchondral bone marrow lesions of the knee: the MOST Study. Ann Rheum Dis 2010, 69(10):1796-1802.
47. Guermazi A., Roemer F.W., Crema M.D., Englund M., Hayashi D. Imaging of non-osteochondral tissues in osteoarthritis. Osteoarthr Cartil 2014, 22(10):1590-1605.
48. Brown M.T., Murphy F.T., Radin D.M., Davignon I., Smith M.D., West C.R. Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. JPain 2012, 13:790-798.
49. Katz N., Borenstein D.G., Birbara C., Bramson C., Nemeth M.A., Smith M.D., et al. Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain 2011, 152:2248-2258.
50. Lane N.E., Schnitzer T.J., Birbara C.A., Mokhtarani M., Shelton D.L., Smith M.D., et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. NEngl J Med 2010, 363:1521-1531.
51. Schnitzer T.J., Ekman E.F., Spierings E.L., Greenberg H.S., Smith M.D., Brown M.T., et al. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Ann Rheum Dis 2014 Mar 13, [Epub ahead of print]. 10.1136/annrheumdis-2013-204905.
52. Balanescu A.R., Feist E., Wolfram G., Davignon I., Smith M.D., Brown M.T., et al. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial. Ann Rheum Dis 2014, 73:1665-1672.
53. Seidel M.F., Wise B.L., Lane N.E. Nerve growth factor: an update on the science and therapy. Osteoarthr Cartil 2013, 21:1223-1228.
54. Holmes D. Anti-NGF painkillers back on track?. Nat Rev Drug Discov 2012, 11:337-338.
55. Hochberg M.C., Abramson S.B., Hungerford D.S., Vignon E.P., Smith M.C., Tive L., et al. Adjudication of reported serious adverse joint events in the Tanezumab clinical development program. Arthritis Rheum 2012, 64:S113.
56. Abramson S.B., Berenbaum F., Hochberg M.C., Moskowitz R.W. Introduction to OARSI FDA initiative OAC special edition. Osteoarthr Cartil 2011, 19(5):475-477.
57. Conaghan P.G., Hunter D.J., Maillefert J.F., Reichmann W.M., Losina E. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthr Cartil 2011, 19(5):606-610.
58. Food and Drug Administration Guidance for Industry Clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA) 1999, [cited 2009 Mar 17]; Available from:. http://www.fda.gov/Cber/gdlns/osteo.htm.
59. Reichmann W.M., Maillefert J.F., Hunter D.J., Katz J.N., Conaghan P.G., Losina E. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthr Cartil 2011, 19(5):550-556.
60. Wirth W., Duryea J., Hellio Le Graverand M.P., John M.R., Nevitt M., Buck R.J., et al. Direct comparison of fixed flexion, radiography and MRI in knee osteoarthritis: responsiveness data from the osteoarthritis initiative. Osteoarthr Cartil 2013, 21(1):117-125.
61. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Reichmann W.M., et al. Responsiveness and reliability of MRI in knee osteoarthritis: a meta-analysis of published evidence. Osteoarthr Cartil 2011, 19(5):589-605.
62. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Li L., et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthr Cartil 2011, 19(5):557-588.
63. Guermazi A., Roemer F.W., Burstein D., Hayashi D. Why radiography should no longer be considered a surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis. Arthritis Res Ther 2011, 13(6):247.
64. Hunter D.J., Nevitt M., Losina E., Kraus V. Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol 2014, 28(1):61-71.
65. Matthews G.L., Hunter D.J. Emerging drugs for osteoarthritis. Expert Opin Emerg Drugs 2011, 16(3):479-491.